Sildenafil Citrate Tablet, Film Coated
Product Images NDC 68071-3670

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Sildenafil Citrate (NDC 68071-3670). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3670 3)

Sildenafil Citrate 25 mg film-coated tablet label by NuCare Pharmaceuticals, Inc. The label shows packaging for 30 tablets, prescription only, with storage instructions between 68-77°F. It includes NDC 68071-3670-3, manufacturer details, barcodes, lot and expiration placeholders, and a warning to keep out of reach of children.*

FDA Label Image

Sildenafil_fig1.jpg (Sildenafil Fig1)

A line graph showing the mean change from baseline in sitting systolic blood pressure over 24 hours in healthy volunteers. The x-axis represents time post dose in hours, and the y-axis shows systolic blood pressure changes in mmHg. Two lines compare Sildenafil 100 mg and placebo effects over time.*

FDA Label Image

Sildenafil_fig3 (Sildenafil Fig 3)

A line graph titled 'Mean Standing Systolic Blood Pressure Change from Baseline' shows changes over time postdose in hours. It compares two groups: one receiving Doxazosin plus placebo and another receiving Doxazosin plus Sildenafil 50 mg, illustrating systolic blood pressure changes in mmHg on the vertical axis.*

FDA Label Image

Sildenafil_fig_4 (Sildenafil Fig 4)

A line graph depicting mean standing systolic blood pressure change from baseline over an 8-hour period after dosing. The graph compares two groups: one receiving Doxazosin with Sildenafil 100 mg, the other with Doxazosin and placebo, showing blood pressure changes in mmHg across time points.*

FDA Label Image

Sidenafil_fig_5 (Sildenafil Fig 5)

A line graph titled 'Figure 5: Mean Sildenafil Plasma Concentrations in Healthy Male Volunteers' showing plasma concentration (ng/ml) on the vertical axis and time post dose (hours) on the horizontal axis. The graph plots the concentration over 24 hours for a commercial tablet, illustrating a rapid peak near 1 hour followed by a decline to near baseline by 24 hours.*

FDA Label Image

Sildenafil-fig7 (Sildenafil Fig7)

Bar graph showing the percentage of patients reporting improvement with Placebo and Sildenafil Tablets at 25 mg, 50 mg, and 100 mg doses. Percentages increase with dose: Placebo 24%, Sildenafil 25 mg 63%, 50 mg 74%, and 100 mg 82%. The x-axis lists treatment groups; the y-axis represents percentage reporting improvement.*

FDA Label Image

Str (Sildenafil Structure)

Chemical structure of sildenafil citrate displaying its molecular arrangement with various functional groups and ring systems.*

FDA Label Image

Figure2 (Sildenafil Fig2)

A line graph showing the change in EBP (mmHg) over time postdose (hours) comparing Doxazosin with placebo and Doxazosin with Sildenafil 25 mg. The x-axis represents time in hours up to 8 hours, and the y-axis represents change in EBP from -40 to 20 mmHg. Two lines track the change for each treatment group over time.*

FDA Label Image

Sildenafil_fig6b (Sildenafil Fig6b)

A bar chart showing the percentage of patients at endpoint compared against baseline scores ranging from 0 to 5. Different bars represent various categories or groups, with the y-axis indicating the percentage of patients and the x-axis showing the baseline score values.*

FDA Label Image

Sildenafil_fig6a (Sildenafil Figure6a)

A bar chart depicting the percentage of patients at endpoint categorized by baseline score ranging from 0 to 5. Multiple bars for each baseline score indicate comparison groups, with a legend showing five group identifiers. The y-axis represents percentage of patients, and the x-axis shows baseline scores.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.